NOVELSTEM INTERNATIONAL CORP.

Press Releases NovelStem International Corp.

Equities

NSTM

US67001V1098

Market Closed - OTC Markets Other stock markets 12:07:06 2024-04-24 EDT			5-day change	1st Jan Change
0.06 ^USD	-.--%		-.--%	-4.61%

04-01	NovelStem International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NOVELSTEM INTERNATIONAL CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-31	AQ
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-01-17	AQ
NOVELSTEM INTERNATIONAL CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers (form 8-K)	22-10-04	AQ
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares	20-12-01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW